These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 17056311

  • 1. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A, Lu SS, Cosman F, Lindsay R, Dempster DW.
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J.
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [Abstract] [Full Text] [Related]

  • 4. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H, Shen V, Dempster DW, Lindsay R.
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
    Oxlund H, Ortoft G, Thomsen JS, Danielsen CC, Ejersted C, Andreassen TT.
    Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
    [Abstract] [Full Text] [Related]

  • 7. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34).
    Wang L, Quarles LD, Spurney RF.
    J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism.
    Friedl G, Turner RT, Evans GL, Dobnig H.
    J Orthop Res; 2007 Nov; 25(11):1454-64. PubMed ID: 17557320
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone (1-34) increased total body bone mass in aged female rats.
    Simmons HA, Pirie CM, Thompson DD, Ke HZ.
    J Pharmacol Exp Ther; 1998 Jul; 286(1):341-4. PubMed ID: 9655878
    [Abstract] [Full Text] [Related]

  • 14. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
    Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM.
    J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
    [Abstract] [Full Text] [Related]

  • 15. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
    McManus JF, Davey RA, Maclean HE, Doust EA, Chiu WS, Sims NA, Bouxsein ML, Glatt V, Zajac JD, Danks JA.
    Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
    [Abstract] [Full Text] [Related]

  • 16. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW, Liang XG, Birchman R, Wu DD, Dempster DW, Lindsay R, Shen V.
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [Abstract] [Full Text] [Related]

  • 17. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
    Fox J, Miller MA, Recker RR, Turner CH, Smith SY.
    Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
    [Abstract] [Full Text] [Related]

  • 18. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
    Washimi Y, Ito M, Morishima Y, Taguma K, Ojima Y, Uzawa T, Hori M.
    Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
    [Abstract] [Full Text] [Related]

  • 19. Anabolic effect of high doses of human parathyroid hormone (1-38) in mature intact female rats.
    Jerome CP.
    J Bone Miner Res; 1994 Jun; 9(6):933-42. PubMed ID: 8079667
    [Abstract] [Full Text] [Related]

  • 20. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT, Samnegård E, Cullen DM, Kimmel DB.
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.